Gestational diabetes & diabetes in pregnancy
Group vs Individual Prenatal Care and Gestational Diabetes Outcomes: A Secondary Analysis of a Randomized Clinical Trial
Primary result · GD incidenceResult — go to the resultAdjusted RD 0.7% 95% CI −1.2% to 2.7%Authors' conclusion
In this secondary analysis of a randomized clinical trial among medically low-risk pregnant individuals, the risk of GD was similar between participants who received GPNC intervention and traditional IPNC, indicating that GPNC may be a feasible treatment option for some patients.
Study context
- Population
- Individuals aged 14 to 45 years with pregnancies earlier than 21 weeks' gestational age, large health care system in Greenville, South Carolina, 2016–20202,144 completed gestational diabetes (GD) screening
- Participants
- 1,176 vs 1,174
- Comparison
- Group prenatal care vs individual prenatal care
- GPNCn = 1,176
- Individual prenatal care (IPNC)n = 1,174reference
- Primary endpoint
- Incidence of GD diagnosed between 24 and 30 weeks of gestation
- Follow-up
- 24 to 30 weeks of gestation
Methodological detailssingle-site, parallel-group
- Single-site
- Parallel-group
Primary result
GD incidence
Adjusted RD
0.7%
95% CI −1.2% to 2.7%
Events by treatment group
GPNCvs IPNC
adjusted RD 0.7% (95% CI −1.2% to 2.7%)
As reported in the abstract
Secondary outcomes
| Outcome | Adjusted RD (95% CI) | |
|---|---|---|
| Progression to A2 GD (among participants with GD) | −6.1% (−21.3% to 9.1%) | |
| Preeclampsia (among participants with GD) | −7.9% (−17.8% to 1.9%) | |
| Cesarean delivery (among participants with GD) | −8.2% (−12.2% to 13.9%) | |
| Large for gestational age (among participants with GD) | −1.2% (−6.1% to 3.8%) | |
| −30−20−1001020Difference (linear scale) |
Original publication
Group vs Individual Prenatal Care and Gestational Diabetes Outcomes: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. Published 1 August 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →